Targeting GM-CSF in rheumatological conditions: risk of PAP Reply

Genovese MC, Buckley CD, Saurigny D, Schett G, Davy K, Gupta A, Smith JE, Patel J, Tak PP (2021)

Publication Type: Journal article, Letter

Publication year: 2021

Journal

The Lancet Rheumatology Elsevier

Book Volume: 3

Pages Range: E473-E474

Journal Issue: 7

DOI: 10.1016/s2665-9913(21)00145-4

Authors with CRIS profile

Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

Stanford University US United States (USA) (US) University of Birmingham GB United Kingdom (GB) GlaxoSmithKline plc. (GSK) GB United Kingdom (GB)

How to cite

APA:

Genovese, M.C., Buckley, C.D., Saurigny, D., Schett, G., Davy, K., Gupta, A.,... Tak, P.P. (2021). Targeting GM-CSF in rheumatological conditions: risk of PAP Reply. The Lancet Rheumatology, 3(7), E473-E474. https://doi.org/10.1016/s2665-9913(21)00145-4

MLA:

Genovese, Mark C., et al. "Targeting GM-CSF in rheumatological conditions: risk of PAP Reply." The Lancet Rheumatology 3.7 (2021): E473-E474.

BibTeX: Download